98%
921
2 minutes
20
Osteoarthritis (OA) is a clinical state which is identified by the degeneration of articular cartilage. OA is a common condition (>500 millions of people affected worldwide), whose frequency is anticipated to continue to rise (> 110 % increase worldwide since 2019). The treatment for early-stage OA is based on a combination of therapeutic approaches, which can include regenerative medicine based on Adipose Derived Stem Cells (ADSCs). Germanium embedded Incrediwear® functional Cred40 fabric has been shown to have positive effects on OA clinically and is envisaged to give encouraging effects also on tissue regeneration. Still, the biological mechanisms underlying this therapeutic modality have not yet been fully defined. We tested the hypothesis that Germanium-embedded Incrediwear® functional Cred40 fabric could enhance chondrogenic differentiation. To this purpose, we applied Incrediwear® to human adipose-derived stem cells (hADSCs) induced to chondrogenic differentiation in vitro. Chondrogenic markers (ACAN, SOX9, RUNX2, COL2A1, COL10A1) were quantified following 21 days of treatment. We also assessed extracellular matrix (ECM) deposition (specifically Collagen and glycosaminoglycans (GAGs)) using Alcian Blue and Sirius Red staining. Here, we provide pilot data to demonstrate that Germanium-embedded Incrediwear® functional Cred40 fabric can enhance hADSCs chondrogenic differentiation and maturity and potentially induce events of cartilage regeneration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.tice.2024.102507 | DOI Listing |
Dev Biol
September 2025
Division of Endocrinology, Boston Children's Hospital, Boston, MA 02115 USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115 USA; Harvard Stem Cell Institute, 7 Divinity Ave, Cambridge, MA 02138 USA. Electronic address:
The mechanisms mediating endochondral bone formation remain incompletely understood. Here, we show that CXXC Finger Protein 1 (CFP1) is required for the onset of chondrogenesis during forelimb development. CFP1-deficient mesenchymal progenitor cells (LMPs) retain an immature molecular signature with elevated FGF and SHH signaling and repressed BMP signaling, in part, due to (1) reduced expression of type I BMP receptors, (2) reduced Smad1 protein levels and (3) an altered extracellular niche.
View Article and Find Full Text PDFRes Vet Sci
September 2025
Laboratorio de Genética Bioquímica LAGENBIO - Instituto de Investigación Sanitaria de Aragón (IIS) - Instituto Agroalimentario de Aragón-IA2, Universidad de Zaragoza-CITA, Zaragoza, Spain; Servicio de Cirugía y Medicina Equina, Hospital Veterinario, Universidad de Zaragoza, Zaragoza, Spain. El
The allogeneic administration of equine mesenchymal stem/stromal cells (MSCs) has numerous advantages over autologous therapy, but their interactions with the patient's immune system need to be further elucidated. These interactions can be influenced by factors such as the compatibility between donor-receptor for the major histocompatibility complex (MHC) and by the MHC expression levels, which can change under different conditions like inflammatory exposure and chondrogeneic differentiation. In this study, we evaluated the local immune response induced by chondrogeneically differentiated (MSC-chondro), pro-inflammatory primed (MSC-primed) and basal (MSC-naïve) MSCs, and how this response changes the immunomodulatory and immunogenic profiles of MSCs in vivo.
View Article and Find Full Text PDFInt J Biol Macromol
September 2025
Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand; Bioplastics Production Laboratory for Medical Applications, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand; Center of Excellence in Materials Science and Technology, Chiang Mai Univ
Early osteoarthritis treatment often relies on viscosupplementation via intra-articular injections, which are limited by inflammation risk and poor cartilage restoration. To address these issues, self-healing hydrogels provide a promising alternative because of their ability to recover structure after mechanical stress. This study reports an injectable self-healing hydrogel composed of N-succinyl chitosan (NSC) and hyaluronic dialdehyde (HAD), combined with kartogenin (KGN), synthesized under mild conditions via Schiff base reactions.
View Article and Find Full Text PDFMater Today Bio
October 2025
Department of Orthopaedic Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
This study aimed to evaluate the effects of cell-derived (BMSCs and chondrocytes) extracellular matrix (ECM) scaffolds incorporating bone marrow aspirate concentrate (BMAC) on cartilage regeneration, and to determine whether BMAC-loaded BMSCs-derived (BM-d) ECM scaffolds were comparable to chondrocytes-derived (Ch-d) ECM scaffolds in terms of cartilage regeneration. In this study, BMSCs and chondrocytes were harvested and isolated, then developed into BM-d and Ch-d ECM scaffolds. The scaffolds were fully immersed in BMAC and subsequently utilized for inducing chondrogenic differentiation in vitro and cartilage regeneration in vivo.
View Article and Find Full Text PDFJ Biochem Mol Toxicol
September 2025
Department of Orthopedics Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Traumatic heterotopic ossification (THO) is a pathological process characterized by ectopic bone formation in soft tissues following trauma or surgical interventions, leading to pain, swelling, and restricted mobility. Current therapeutic strategies remain limited, with surgical excision often associated with recurrence and complications. Triptolide (TP), a diterpenoid triepoxide derived from Tripterygium wilfordii, has potent anti-inflammatory and immunomodulatory effects, making it a promising candidate for THO treatment.
View Article and Find Full Text PDF